Rosen Law Firm urges Unicycive Therapeutics investors to secure counsel before November 2 class action deadline
Summary
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to secure counsel before an important November 2 deadline in a securities class action. The notice is a New York press release dated October 25, 2026, distributed through Newsfile Corp. and carried by Business Insider.
Timeline
Business Insider
Source ↗Business Insider reports that Rosen Law Firm reminds Unicycive Therapeutics, Inc. investors to secure counsel before the November 2 deadline in a securities class action.
Comments
No comments yet.
to like and comment.